Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study

Clinical Transplantation

Volumn 12, Issue 5, 1998, Pages 371-374

  Sarmiento, Juan M ^a   Munn, Stephen R ^a   Paya, Carlos V ^a   Velosa, Jorge A ^a   Nguyen, Justin H ^a  

^a MAYO CLINIC   (United States)

Author keywords

Case control study; CMV status; Cytomegalovirus; Kidney transplantation; Mycophenolate mofetil; Rejection

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VIREMIA;

ADULT; AZATHIOPRINE; CASE-CONTROL STUDIES; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMP DEHYDROGENASE; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; OPPORTUNISTIC INFECTIONS; PREDNISONE; RISK FACTORS;

EID: 0031663952     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. SOLLINGER HS. From mice to man: the preclinical history of mycophenolate mofetil. Clin Transplant 1996: 10: 85.
2. EUGUI EM, ALLISON AC. Immunosuppressive activity of mycophenolate mofetil. Ann NY Acad Sci 1993: 685: 309.
3. SOLLINGER HS, DEIERHOI MH, BELZER FO, DIETHELM AG, KAUFFMAN RS. RS-61443 - a phase I clinical trial and pilot rescue study. Transplantation 1992: 53: 428.
4. MORRIS RE, WANG J, BLUM JR et al. Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients in heart allografts. Transplant Proc 1991: 23 (Suppl. 2): 19.
5. HAO L, CALCINARO F, GILL RG, EUGUI EM, ALLISON AC, LAFFERTY KJ. Facilitation of specific tolerance induction in adult mice by RS-61443. Transplantation 1992: 53: 590.
6. NAKAJIMA K, OCHIAI T, NAGATA M et al. Effects of triple therapy of cyclosporine, FK 506 and RS-61443 on allogenic small bowel transplanatation in dogs. Transplant Proc 1993: 25: 595.
7. ALLISON AC, EUGUI EM. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 1993: 136: 1.
8. ALFIERI C, ALLISON AC, KIEFF E. Effect of mycophenolic acid on Epstein-Barr virus infection of human lymphocytes- Antimicroc Agents Chemother 1994: 38: 126.
9. ALLISON AC, EUGUI EM. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 1996: 10: 77.
10. KAHAN BD, CHOBRIAL R. Immunosuppressive agents. Surg Clin North Am 1994: 74: 1029.
11. ANONYMOUS. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1996: 61: 1029.
12. SOLLINGER HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995: 60: 225.
13. ANONYMOUS. Placebo-controlled study of mycophenolate mofetil combined with cyclosporine and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet 1995: 345: 1321.
14. RUBIN RH. Impact of cytomegalovirus infection on organ transplant recipients. Rev Infect Dis 1990: 12: 754.
15. HIBBERD PL, RUBIN RH. Renal transplantation and related infections. Semin Respir Infect 1993: 8: 216.
16. RUBIN RH. Infection in the organ transplant patient. In: RUBINS RH, YOUNG LS, eds. Clinical approach to infection in immunocompromised host. New York: Plenum, 1994.